We confirmed for the first time that the polyphenolic compound MBC attenuated NAFLD in vitro by decreased hepatic lipid synthesis and reduced inflammation through the AMPK and NF-κB signaling pathways. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.